Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis

被引:36
作者
Goupil, Remi [1 ]
Benlarbi, Mehdi [2 ]
Beaubien-Souligny, William
Nadeau-Fredette, Annie-Claire [3 ]
Chatterjee, Debashree [2 ]
Goyette, Guillaume [2 ]
Gunaratnam, Lakshman [4 ,5 ]
Lamarche, Caroline [3 ]
Tom, Alexander [6 ]
Finzi, Andres [2 ,7 ,8 ]
Suri, Rita S. [2 ,6 ,9 ]
机构
[1] Hop Sacre Coeur Montreal, Ctr Rech, Montreal, PQ, Canada
[2] Ctr Hosp Univ Montreal CHUM, Ctr Rech, Montreal, PQ, Canada
[3] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada
[4] Western Univ, Dept Microbiol & Immunol, London, ON, Canada
[5] Western Univ, Dept Med, Div Nephrol, London, ON, Canada
[6] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada
[7] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada
[8] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
[9] McGill Univ, Div Nephrol, Dept Med, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
PROTECTION; DIALYSIS;
D O I
10.1503/cmaj.210673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Patients receiving in-centre hemodialysis are at high risk of exposure to SARS-CoV-2 and death if infected. One dose of the BNT162b2 SARS-CoV-2 vaccine is efficacious in the general population, but responses in patients receiving hemodialysis are uncertain. METHODS: We obtained serial plasma from patients receiving hemodialysis and health care worker controls before and after vaccination with 1 dose of the BNT162b2 mRNA vaccine, as well as convalescent plasma from patients receiving hemodialysis who survived COVID-19. We measured anti-receptor binding domain (RBD) immunoglobulin G (IgG) levels and stratified groups by evidence of previous SARS-CoV-2 infection. RESULTS: Our study included 154 patients receiving hemodialysis (135 without and 19 with previous SARS-CoV-2 infection), 40 controls (20 without and 20 with previous SARS-CoV-2 infection) and convalescent plasma from 16 patients. Among those without previous SARS-CoV-2 infection, anti-RBD IgG was undetectable at 4 weeks in 75 of 131 (57%, 95% confidence interval [CI] 47% to 65%) patients receiving hemodialysis, compared with 1 of 20 (5%, 95% CI 1% to 23%) controls (p < 0.001). No patient with nondetectable levels at 4 weeks developed anti-RBD IgG by 8 weeks. Results were similar in non-immunosuppressed and younger individuals. Three patients receiving hemodialysis developed severe COVID-19 after vaccination. Among those with previous SARS-CoV-2 infection, median anti-RBD IgG levels at 8 weeks in patients receiving hemodialysis were similar to controls at 3 weeks (p = 0.3) and to convalescent plasma (p = 0.8). INTERPRETATION: A single dose of BNT162b2 vaccine failed to elicit a humoral immune response in most patients receiving hemodialysis without previous SARS-CoV-2 infection, even after prolonged observation. In those with previous SARS-CoV-2 infection, the antibody response was delayed. We advise that patients receiving hemodialysis be prioritized for a second BNT162b2 dose at the recommended 3-week interval.
引用
收藏
页码:E793 / E800
页数:8
相关论文
共 25 条
[1]   Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021 [J].
Abu Jabal, Kamal ;
Ben-Amram, Hila ;
Beiruti, Karine ;
Batheesh, Yunis ;
Sussan, Christian ;
Zarka, Salman ;
Edelstein, Michael .
EUROSURVEILLANCE, 2021, 26 (06)
[2]   High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples [J].
Anand, Sai Priya ;
Prevost, Jeremie ;
Richard, Jonathan ;
Perreault, Josee ;
Tremblay, Tony ;
Drouin, Mathieu ;
Fournier, Marie-Josee ;
Lewin, Antoine ;
Bazin, Renee ;
Finzi, Andres .
TRANSFUSION, 2021, 61 (05) :1377-1382
[3]   Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination [J].
不详 .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :E281-E283
[4]  
[Anonymous], 2021, AN ADV COMM STAT ACS
[5]   Discrete SARS-CoV-2 antibody titers track with functional humoral stability [J].
Bartsch, Yannic C. ;
Fischinger, Stephanie ;
Siddiqui, Sameed M. ;
Chen, Zhilin ;
Yu, Jingyou ;
Gebre, Makda ;
Atyeo, Caroline ;
Gorman, Matthew J. ;
Zhu, Alex Lee ;
Kang, Jaewon ;
Burke, John S. ;
Slein, Matthew ;
Gluck, Matthew J. ;
Beger, Samuel ;
Hu, Yiyuan ;
Rhee, Justin ;
Petersen, Eric ;
Mormann, Benjamin ;
Aubin, Michael de St ;
Hasdianda, Mohammad A. ;
Jambaulikar, Guruprasad ;
Boyer, Edward W. ;
Sabeti, Pardis C. ;
Barouch, Dan H. ;
Julg, Boris D. ;
Musk, Elon R. ;
Menon, Anil S. ;
Lauffenburger, Douglas A. ;
Nilles, Eric J. ;
Alter, Galit .
NATURE COMMUNICATIONS, 2021, 12 (01)
[6]   Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals [J].
Beaudoin-Bussieres, Guillaume ;
Laumaea, Annemarie ;
Anand, Sai Priya ;
Prevost, Jeremie ;
Gasser, Romain ;
Goyette, Guillaume ;
Medjahed, Halima ;
Perreault, Josee ;
Tremblay, Tony ;
Lewin, Antoine ;
Gokool, Laurie ;
Morrisseau, Chantal ;
Begin, Philippe ;
Tremblay, Cecile ;
Martel-Laferriere, Valerie ;
Kaufmann, Daniel E. ;
Richard, Jonathan ;
Bazin, Renee ;
Finzi, Andres .
MBIO, 2020, 11 (05) :1-7
[7]   Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine [J].
Bradley, Todd ;
Grundberg, Elin ;
Selvarangan, Rangaraj ;
LeMaster, Cas ;
Fraley, Elizabeth ;
Banerjee, Dithi ;
Belden, Bradley ;
Louiselle, Daniel ;
Nolte, Nick ;
Biswell, Rebecca ;
Pastinen, Tomi ;
Myers, Angela ;
Schuster, Jennifer .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1959-1961
[8]   Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 [J].
Ebinger, Joseph E. ;
Fert-Bober, Justyna ;
Printsev, Ignat ;
Wu, Min ;
Sun, Nancy ;
Prostko, John C. ;
Frias, Edwin C. ;
Stewart, James L. ;
Van Eyk, Jennifer E. ;
Braun, Jonathan G. ;
Cheng, Susan ;
Sobhani, Kimia .
NATURE MEDICINE, 2021, 27 (06) :981-+
[9]   Humoral Responses and Serological Assays in SARS-CoV-2 Infections [J].
Galipeau, Yannick ;
Greig, Matthew ;
Liu, George ;
Driedger, Matt ;
Langlois, Marc-Andre .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[10]   Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis [J].
Grupper, Ayelet ;
Sharon, Nechama ;
Finn, Talya ;
Cohen, Regev ;
Israel, Meital ;
Agbaria, Amir ;
Rechavi, Yoav ;
Schwartz, Idit F. ;
Schwartz, Doron ;
Lellouch, Yonatan ;
Shashar, Moshe .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07) :1037-1042